Weight loss: Illegal retatrutide pharmacy sales ‘being looked at’

magnifying glass over GLP-1 written on scrap of paper. other paper scraps read "obesity," "semaglutide" "weight loss"
Retatrutide is an unlicensed drug currently in clinical trials for obesity (Shutterstock)
Darcy Jimenez

Read more by Darcy Jimenez

Darcy became managing editor at C+D in April 2026, after joining as a senior reporter the previous August. She has been a journalist for several years, writing news and features across a range of areas, including healthcare and the pharmaceutical industry.

Latest from Regulation

More from News